Uro-oncologic patient management during the COVID-19 pandemic: survey findings from an Italian oncologic hub.
Future Oncol
; 17(27): 3615-3625, 2021 Sep.
Article
in En
| MEDLINE
| ID: mdl-34278823
Lay abstract We provide robust evidence that an oncologic hub center during COVID-19 pandemic represents a credible solution for management of non-deferrable uro-oncologic patients. Specifically, surgical treatment at a hub center of patients coming from spoke centers is well accepted by both patients and hospital staff members. Moreover, collaboration between healthcare workers from spoke and hub centers generates minimal levels of anxiety, while potentially being associated with clinical, surgical and scientific improvement. This said, a more specific focus on recommended strategies to reduce the risk of SARS-CoV-2 contagion at oncologic hub hospitals is warranted.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Attitude of Health Personnel
/
Urologic Neoplasms
/
Patient Satisfaction
/
COVID-19
Type of study:
Diagnostic_studies
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Future Oncol
Year:
2021
Type:
Article
Affiliation country:
Italy